文献速递糖尿病

2型糖尿病成人睡眠时长与死亡风险的关联:一项前瞻性队列研究

Association between sleep duration and mortality risk among adults with type 2 diabetes: a prospective cohort study.
PubMed 文献 · Diabetologia · 2020-07-16

该前瞻性队列纳入2004至2013年美国国家健康访谈调查中273,029名成人(含24,212名2型糖尿病者),随访至2015年12月31日。在2型糖尿病者中,睡眠时长与全因死亡风险呈J形关系,以每日7小时为参照,过短或过长睡眠均与全因死亡风险升高相关。

要点

  • 2型糖尿病者中,睡眠≤5、6、8和≥10小时/天均与全因死亡风险升高相关(以7小时/天为参照)。
  • 睡眠时长与糖尿病状态的交互作用未达统计学显著(交互作用P=0.08)。
  • 较年轻发病及同时使用口服降糖药和胰岛素者中,睡眠时长与死亡风险的关联更明显。

核心结论

  • 在2型糖尿病者中,睡眠少于或多于每日7小时与全因死亡及特定原因死亡风险升高相关。
  • 该关联在发病年龄较轻和同时接受口服降糖药与胰岛素治疗者中更明显,该人群可能从针对性睡眠干预中获益以降低不良健康结局风险。

研究设计与样本

  • 前瞻性队列研究,样本为2004至2013年美国国家健康访谈调查的273,029名成人,其中无糖尿病者248,817名、2型糖尿病者24,212名,数据链接至2015年12月31日的死亡数据库。
  • 睡眠时长采用自我报告,询问参与者「平均每天睡多久(≤5、6、7、8、9或≥10小时/天)」。
  • 采用Cox比例风险回归模型分析睡眠时长与死亡风险的关系,并校正人口学、BMI、生活方式行为和临床变量。

主要发现

  • 糖尿病成人中睡眠时长极端者的绝对死亡率更高:≤5小时/天为每万人年215.0,≥10小时/天为每万人年363.5。
  • 睡眠时长与糖尿病状态的交互作用未达统计学显著(交互作用P=0.08)。
  • 2型糖尿病者中睡眠时长与全因死亡风险呈J形关系;以每日7小时为参照,≤5小时/天HR 1.24(95%CI 1.09,1.40),6小时/天HR 1.13(95%CI 1.01,1.28),8小时/天HR 1.17(95%CI 1.06,1.30),≥10小时/天HR 1.83(95%CI 1.61,2.08)。
  • 心血管疾病、癌症、肾病、阿尔茨海默病和慢性下呼吸道疾病死亡风险也观察到类似关联。
  • 发病年龄较轻者中较长睡眠时长与更高的全因和心血管疾病死亡风险相关;同时使用胰岛素和口服降糖药者中较短睡眠时长与更高的全因和心血管疾病死亡风险相关。

局限性

  • 睡眠时长采用自我报告测量。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS/HYPOTHESIS: This study aimed to investigate whether the effects of sleep duration interacted with the presence of diabetes. We specifically sought to examine the relationship between sleep duration and all-cause and cause-specific mortality in people with type 2 diabetes across sex, age at diagnosis, duration of diabetes and treatment type. METHODS: The sample consisted of 273,029 adults, including 248,817 without diabetes and 24,212 with type 2 diabetes, who participated in the National Health Interview Survey from 2004 to 2013 and whose data were linked to a mortality database up to 31 December 2015. Sleep duration was measured using self-report, whereby participants were asked 'on average how long do you sleep each day (≤5, 6, 7, 8, 9 or ≥10 h/day)?' The relationship between sleep duration and mortality risk was investigated using Cox proportional hazards regression model, with adjustments for demographics, BMI, lifestyle behaviours and clinical variables. RESULTS: Absolute mortality rate was higher in adults with diabetes and extremes of sleep duration (≤5 h/day, 215.0 per 10,000 person-years; ≥10 h/day, 363.5 per 10,000 person-years). There was a non-significant interaction between sleep duration and the presence of diabetes (p for interaction = 0.08). A J-shaped relationship existed between sleep duration and all-cause mortality risk in people with type 2 diabetes. Compared with the reference group (7 h/day), both shorter and longer sleep durations were associated with increased risk of all-cause mortality (≤5 h/day, HR 1.24 [95% CI 1.09, 1.40]; 6 h/day, HR 1.13 [1.01, 1.28]; 8 h/day, HR 1.17 [1.06, 1.30]; ≥10 h/day, HR 1.83 [1.61, 2.08]). Similar associations were also observed for mortality risk from CVD, cancer, kidney disease, Alzheimer's disease and chronic lower respiratory diseases. Longer sleep duration in those with a younger age at diabetes onset was associated with greater risks of all-cause and CVD mortality. Shorter sleep duration in individuals treated with both insulin and oral glucose-lowering medication was also associated with higher risks of all-cause and CVD mortality. CONCLUSIONS/INTERPRETATION: The associations between sleep duration and mortality risk may be different between diabetic and non-diabetic individuals. In people with type 2 diabetes, sleeping less or more than 7 h/day was associated with increased risk of all-cause and condition-specific mortality. The association was more prominent in those with a younger age at diabetes onset and receiving treatment with both oral glucose-lowering medication and insulin. This population may benefit from targeted sleep-related interventions to reduce the risks of adverse health outcomes. Graphical abstract.

来源:Diabetologia,查看原文。版权归原作者所有。

引用

  1. Wang Y, Huang W, O'Neil A, et al. Association between sleep duration and mortality risk among adults with type 2 diabetes: a prospective cohort study. Diabetologia. 2020. PMID: 32671413. doi:10.1007/s00125-020-05214-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。